These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15641881

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome and catatonia overlapping: 2 case reports.
    Loeb E, Madigand J, Alexandre J, Dollfus S, Coquerel A, Fedrizzi S.
    Psychopharmacology (Berl); 2015 Jul; 232(14):2643-4. PubMed ID: 26047965
    [No Abstract] [Full Text] [Related]

  • 4. Catatonia: a syndrome appears, disappears, and is rediscovered.
    Fink M.
    Can J Psychiatry; 2009 Jul; 54(7):437-45. PubMed ID: 19660165
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome and its controversies.
    Margetić B, Aukst-Margetić B.
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [Abstract] [Full Text] [Related]

  • 7. Still trying to solve the catatonic dilemma--A comment on the Letter to the Editor by Loeb et al. (Psychopharmacology, 2015).
    Lang FU, Lang S, Becker T, Jäger M.
    Psychopharmacology (Berl); 2015 Jul; 232(14):2645-6. PubMed ID: 26051547
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroleptic malignant syndrome and catatonia: one entity or two?
    Fink M.
    Biol Psychiatry; 1996 Jan 01; 39(1):1-4. PubMed ID: 8719118
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.
    Lang FU, Lang S, Becker T, Jäger M.
    Psychopharmacology (Berl); 2015 Jan 01; 232(1):1-5. PubMed ID: 25407348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.
    World J Biol Psychiatry; 2009 Jan 01; 10(1):70-3. PubMed ID: 19673089
    [Abstract] [Full Text] [Related]

  • 15. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome.
    Am J Psychiatry; 1989 Sep 01; 146(9):1240-2. PubMed ID: 2569842
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.